SCHEMBL2960740

SCHEMBL2960740

Brc1c(-c2cccc3ccccc23)ccc2c1C=CC2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.33
HTR7 P34969 2/20 0.33
NISCH Q9Y2I1 1/20 0.33
ALDH1A1 P00352 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.32
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
ALOX5 P09917 1/20 0.31
KDM4E B2RXH2 2/20 0.30
GAA P10253 2/20 0.30
PTPN1 P18031 1/20 0.30
ALPL P05186 1/20 0.30
MAPT P10636 2/20 0.30
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6056141 0.82 HTR7 (0.39) HTR1AHTR7NISCHALDH1A1CYP1A2
SCHEMBL6055938 0.81 HTR7 (0.31) HTR1AHTR7NISCHALDH1A1CYP1A2
Lithium SCHEMBL29767605 0.81 HTR7 (0.38) HTR1AHTR7NISCHALDH1A1CYP1A2
SCHEMBL28418857 0.81 HTR7 (0.38) HTR1AHTR7NISCHALDH1A1CYP1A2
SCHEMBL2971247 0.81 DHFR (0.33) NISCHALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2965041 0.80 MAOA (0.33) HTR1AHTR7NISCHALDH1A1CYP1A2
SCHEMBL2970904 0.78 KDM4E (0.36) HTR1AHTR7NISCHALDH1A1CYP1A2
SCHEMBL2959125 0.77 MAOA (0.33) HTR1AHTR7NISCHALDH1A1CYP1A2
SCHEMBL2972198 0.76 CYP1A2 (0.36) HTR1AHTR7NISCHALDH1A1CYP1A2
SCHEMBL2971023 0.76 HTR1A (0.33) HTR1AHTR7NISCHALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 HTR1A 2170/4885HTR7 2417/4885NISCH 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.